Successful Treatment of Atopic Dermatitis with Dupilumab in a Patient with Non-Hodgkin’s Lymphoma

Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study

Mette Deleuran, Diamant Thaçi, Lisa A. Beck et al. · Journal of the American Academy of Dermatology · 2019 · 248 citations · Full text

Progression of cutaneous T-cell lymphoma after dupilumab: Case review of 7 patients

Maria L. Espinosa, Morgan Nguyen, Amaia Saenz Aguirre et al. · Journal of the American Academy of Dermatology · 2020 · 121 citations · Full text

Cutaneous T-cell Lymphoma, Lymphoid Neoplasia, Case Review +8

Lymphoma among patients with atopic dermatitis and/or treated with topical immunosuppressants in the United Kingdom

Félix Arellano, Alejandro Arana, Charles Wentworth et al. · Journal of Allergy and Clinical Immunology · 2009 · 93 citations

Drug Hypersensitivity, Topical Immunosuppressants, Atopic Dermatitis And/or +7

Association Between Atopic Eczema and Cancer in England and Denmark

Kathryn E. Mansfield, Sigrún Alba Jóhannesdóttir Schmidt, Bianka Darvalics et al. · JAMA Dermatology · 2020 · 88 citations · Full text

Two Cancer Patients Receiving Dupilumab for Treatment of Atopic Dermatitis

Emilie Fowler, Jordan Rosen, Hadar Lev‐Tov et al. · Acta Dermato Venereologica · 2019 · 24 citations · Full text